Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
zydus
1 Injection
Trustuzumab
Keep in cold place
Delivering To:
Overview
Vivitra 440mg Injection is an anticancer medicine that helps to treat breast, gastric, and gastroesophageal cancer. It is used when cancer cells spread to other parts of the body. Trastuzumab, the active ingredient in Vivitra 440mg Injection, is used for the treatment of HER2 breast cancer. Additionally, metastatic gastric cancer with elevated HER2 protein levels is treated with this drug. For patients under the age of 18, as well as those who require oxygen therapy or have serious respiratory issues, Vivitra 440mg Injection is not advised. If you have ever received any kind of cancer therapy, have cardiac issues, or experience dyspnea, you must inform your doctor. Before beginning therapy with this medication, make sure you tell your doctor about all the medications you are taking, including herbal and supplement medications.
Breast Cancer
Vivitra 440mg Injection is indicated for use in the following conditions:
Advanced and metastatic breast cancer
Metastatic gastric cancer
Vivitra 440mg Injection causes several side effects, which are unwanted symptoms that include:
Chills and Cough
Anemia
Decrease in blood cell counts
Diarrhea
Fatigue
Fever
Headache
Heart failure
Mucosal inflammation
Infection in the upper respiratory
Weight loss
If the patients are suffering from the above-mentioned symptoms, do not avoid these symptoms because this injection has severe side effects. Try to contact the doctor immediately for urgent help.
Vivitra is taken in injection form as per the doctor's prescription. The patients should take this injection from a qualified medical professional. To get benefits soon, take this injection strictly according to the doctor's prescription. Taking this injection in the wrong way may give you severe side effects.
Vivitra 440mg binds the HER2 protein on the surface of cancer cells. The blocking of the HER2 receptor stops signaling, which will stop the growth and division of cancer cells in the patient's body. The benefits of the injection are seen in a few weeks or months, depending on the health of the patients after starting treatment. However, to see the full benefit, it can take several months or years. As to healthcare professionals. Vivitra is a powerful and very effective injection for the treatment of breast cancer. However, patients need to discuss of benefits and side effects at the beginning of treatment.
Alcohol
unsafe
It is advisable not to consume alcohol while taking medicine.
Pregnancy
consult your doctor
Do not take Vivitra 440mg Injection without consulting the doctor, in case of pregnancy.
Breast Feeding
consult your doctor
Without a doctor's consultation, do not take this medicine if you're breastfeeding.
Driving
danger
It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of the medicine.
Kidney
caution
Do not take Vivitra 440mg Injection without a doctor's consultation in case of kidney problems.
Liver
caution
Share your medical history with the doctor in case of liver disease before taking this medicine.
It is advisable not to miss any dose. In case you miss a dose of Vivitra 440mg Injection consult your doctor soon. Missing the dose will impact the overall health of the patients. So, it is always advisable to follow the prescription of the doctor strictly.
The Vivitra injection is used to treat breast, gastric, and gastroesophageal cancer.
Store this injection below 30 degrees temperature in a dry place.
Pregnant women should consult with their doctor first before taking this medicine.
It depends on the stage of cancer and the health of the patients.
Vivitra injection is administered by a professional doctor.
In reality, the injection of Vivitra 440mg has a risk to harm the heart muscles. Therefore, it is recommended to get a cardiac checkup every three months and to continue doing so for two to five years after the end of treatment in order to prevent the symptoms from getting worse.
Wierzbicki, R., Slamon, D. J., Leyland‑Jones, B., Shak, S., Fuchs, H., Paton, V. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New England Journal of Medicine, 344(11), 783–792.
Gelber, R. D., Piccart‑Gebhart, M. J., Procter, M., Leyland‑Jones, B., Goldhirsch, A., Untch, M. (2005). Trastuzumab after adjuvant chemotherapy in HER2‑positive breast cancer. New England Journal of Medicine, 353(16), 1659–1672.
Tabernero, J., Bang, Y.‑J., Van Cutsem, E., Feyereislova, A., Chung, H.‑C., Shen, L. (2010). Trastuzumab in combination with chemotherapy versus chemotherapy alone for HER2‑positive advanced gastric or gastroesophageal junction cancer: a phase III, open‑label, randomised controlled trial (ToGA). Lancet, 376(9742), 687–697.
Zydus Cadila. (2025). Vivitra™ (trastuzumab) prescribing information. Retrieved from the company's information site Macarius Health. (2025). Vivitra 440 mg injection (biosimilar trastuzumab): Product profile. Retrieved from the oncology product database
